Basic Information
Basic information for UCA1-245-11aa-2
Peptide Name UCA1-245-11aa-2
Genome Position chr19:15835940-15835972[+]
Species Human
Peptide Sequence MSPIISPPCTL
Peptide Length 11
Unique No (UCA1-201-11aa,UCA1-204-11aa,UCA1-206-11aa,UCA1-209-11aa,UCA1-213-11aa-1,UCA1-213-11aa-2,UCA1-214-11aa,UCA1-216-11aa-1,UCA1-216-11aa-2,UCA1-219-11aa,UCA1-221-11aa,UCA1-226-11aa,UCA1-228-11aa-1,UCA1-228-11aa-2,UCA1-229-11aa-1,UCA1-229-11aa-2,UCA1-231-11aa,UCA1-234-11aa,UCA1-236-11aa,UCA1-237-11aa,UCA1-238-11aa-1,UCA1-238-11aa-2,UCA1-239-11aa,UCA1-240-11aa,UCA1-242-11aa,UCA1-243-11aa,UCA1-244-11aa)
Grand Average of Hydropathicity 0.9182
Relative Molecular Mass 1338.61
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000214049;UCA1
Transcript ID/Name ENST00000671188;UCA1-245
Transcript Length 1287
Coding Ability 0.4118
DNA Sequence Corresponding to Peptide ATGAGTCCCATCATCTCTCCACCATGCACCTTG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :